Expression of Bax, a pro-apoptotic member of the Bcl-2 family, in esophageal squamous cell carcinoma

International Journal of Cancer

Volumn 73, Issue 4, 1997, Pages 508-513

  Sarbia, Mario ^a   Bittinger, Fernando ^b   Grabellus, Florian ^a   Verreet, Patrick ^a   Dutkowski, Philipp ^b   Willers, Rainhart ^a   Gabbert, Helmut E ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER INVASION; DISEASE ASSOCIATION; ESOPHAGUS CARCINOMA; GENE MUTATION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIGENE FAMILY; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN ANALYSIS; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; REGRESSION ANALYSIS; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED;

EID: 0031455361     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19971114)73:4<508::AID-IJC9>3.0.CO;2-3     Document Type: Article

References (28)

1. CAMPOS, L., ROUALUIT, J.P., SABIDO, O., ROUBI, N., VASSELON, C., ARCHIMBAUD, E., MAGAUD, J.P. and GUYOTAT, D., High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood, 81, 3091-3096 (1993).
2. EARLAM, R. and CUNHA-MELO, J.R., Oesophageal squamous cell carcinoma: I. A critical review of surgery. Brit. J. Cancer, 67, 381-390 (1980).
3. HERMANEK, P. and SOBIN, L.H. (eds.), TNM classification of malignant tumours (4th ed., 2nd rev.), Springer-Verlag, Berlin (1992).
4. HICKMAN, J.A., Apoptosis induced by anticancer drugs. Cancer Metastasis Rev., 11, 121-139 (1992).
5. ILSEN, D.H. and KELSEN, D.P., Combined modality therapy in the treatment of esophageal cancer. Semin. Oncol., 21, 493-507 (1994).
6. ISAACS, J.T., Advances and controversies in the study of programmed cell death/apoptosis in the development of and therapy for cancer. Curr. Opin. Oncol., 6, 82-89 (1994).
7. JOENSUU, H., PYKLANEN, L. and TOIKKANEN, S., Bcl-2-protein expression and long-term survival in breast cancer. Amer. J. Pathol., 145, 1191-1198 (1994).
8. KITADA, S., KRAJEWSKI, S., MIYASHITA, T., KRAJEWSKA, M. and REED, J.C., Gamma-radiation induces upregulation of Bax protein and apoptosis in radiosensitive cells in vivo. Oncogene, 12, 187-192 (1996).
9. KRAJEWSKA, M., FENOGLIO-PREISER, C.M., KRAJEWSKI, S., SONG, K., MACDONALD, J.S., STEMMERMANN, G. and REED, J.C., Immunohistochemical analysis of Bcl-2 family proteins in adenocarcinomas of the stomach. Amer. J. Pathol., 149, 1449-1457 (1996a).
10. KRAJEWSKA, M., KRAJEWSKI, S., EPSTEIN, J.I., SHABAIK, A., SAUVAGEOT, J., SONG, K., KITADA, S. and REED, J.C., Immunohistochemical analysis of bcl-2, bax, bcl-X and mcl-1 expression in prostate cancers. Amer. J. Pathol., 148, 1567-1576 (1996b).
11. KRAJEWSKA, M., MOSS, S.F., KRAJEWSKI, S., SONG, K., HOLT, P.R. and REED, J.C., Elevated expression of bcl-X and reduced bak in primary colorectal adenocarcinoma. Cancer Res., 56, 2422-2427 (1996c).
12. KRAJEWSKI, S., BLOMQVIST, C., FRANSSILA, K., KRAJEWSKA, M., WASENIUS, V.M., NISKANEN, E., NORDLING, S. and REED, J.C., Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res., 55, 4471-4478 (1995).
13. MAJNO, G. and JORIS, I., Apoptosis, oncosis, and necrosis - an overview of cell death. Amer. J. Pathol., 146, 3-15 (1995).
14. MCDONNELL, T.J., TRONCOSO, P., BRISBAY, S.M., LOGOTHETIS, C., CHUNG, L.W.K., HSIEH, J.T., TU, S.M. and CAMPBELL, M.L., Expression of the proto-oncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res., 52, 6940-6944 (1992).
15. MEYN, R.E., STEPHENS, L.C. and MILAS, L., Programmed cell death and radioresistance. Cancer Metastasis Rev., 15, 119-131 (1996).
16. MIYASHITA, T., KRAJWSKI, S., KRAJEWSKA, M., WANG, H.G., LIN, H.K., HOFFMAN, B., LIEBERMAN, D. and REED, J.C., Tumor suppressor p53 is a regulator of bcl-2 and box gene expression in vitro and in vivo. Oncogene, 9, 1799-1805 (1994).
17. OLTVAI, Z.N., MILLIMAN, C.L. and KORSMEYER, S.J., Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 74, 609-619 (1993).
18. PEZZELLA, F., TURLEY, H., KUZU, I., TUNGEKAR, M.H., DUNNILL, M.S., PIERCE, C.B., HARRIS, A., GATTER, K.C. and MASON, D.Y., bcl-2 protein in non-small-cell lung carcinoma. N. Engl. J. Med., 329, 690-694 (1993).
19. REED, J.C., MIYASHITA, T., TAKAYAMA, S., WANG, H.G., SATO, T., KRAJEWSKI, S., AIMÉ-SEMPÉ, C., BOFRUG, S., KITADA, S. and HANADA, M., BCL-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. J. cell. Biochem., 60, 23-32 (1996).
20. SARBIA, M., BITTINGER, F., FORSCHEN, R., VERREET, P., DUTKOWSKI, P., WILLERS, R. and GABBERT, H.E., bcl-2 expression and prognosis in squamous-cell carcinomas of the esophagus. Int. J. Cancer, 69, 324-328 (1996).
21. SARBIA, M., BÖSING, N., HILDEBRANDT, B., KOLDOVSKY, P., GERHARZ, C.D. and GABBERT, H.E., Characterization of two newly established cell lines derived from squamous cell carcinomas of the oesophagus. Anticancer Res., 17, 2185-2192 (1997).
22. SEDLAK, T.W., OLTVAI, Z.N., YANG, E., WANG, K., BOISE, L.H., THOMPSON, C.B. and KORSMEYER, S.J., Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc. nat. Acad. Sci. (Wash.), 92, 7834-7838 (1995).
23. WORLD HEALTH ORGANIZATION, Histological typing of oesophageal and gastric tumours (2nd ed.), Springer-Verlag, Berlin (1990).
24. YIN, C., KNUDSON, C.M., KORSMEYER, S.J. and VAN DYKE, T., Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature (Lond.), 385, 637-640 (1997).
25. YIN, X.M., OLTVAI, Z.N. and KORSMEYER, S.J., BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerisation with Bax. Nature (Lond.), 369, 321-323 (1994).
26. YUNIS, J.J., MAYER, M.G., ARENSEN, M.A., AEPPLI, D.P., OKEN, M.M. and FRIZZERA, G., Bcl-2 and other genomic alterations in the prognosis of large-cell lymphomas. N. Engl. J. Med., 320, 1047-1054 (1989).
27. ZHA, H., AIMÉ-SEMPÉ, C., SATO, T. and REED, J.C., Pro-apoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2. J. biol. Chem., 271, 7440-7444 (1996).
28. ZHAN, Q., FAN, S., BAE, I., GUILOUF, C., LIEBERMANN, D.A., O'CONNOR, P.M. and FORNACE, JR., A.J., Induction of bax by genotypic stress in human cells correlates with p53 status and apoptosis. Oncogene, 9, 3743-3751 (1994).